++
For further information, see CMDT Part 26-32: Gynecomastia
+++
Essentials of Diagnosis
++
Palpable enlargement of the male breast, often asymmetric or unilateral
Fatty gynecomastia is typically nontender
Glandular gynecomastia is tender
Gynecomastia must be distinguished from carcinoma or mastitis
+++
General Considerations
++
Endocrine (Table 26–14)
Hyperprolactinemia
Hyperthyroidism
Klinefelter syndrome
Hypogonadism
Systemic disease: chronic liver or kidney disease
Neoplasm
Testicular
Adrenal
Lung
Liver (rare)
Drugs (selected)
Alcohol, marijuana
Amiodarone
Cimetidine, omeprazole
Diazepam
Digoxin
Estrogens, progestins, testosterone
Finasteride
Flutamide
Isoniazid
Ketoconazole
Opioids
Spironolactone
Tricyclic antidepressants
Pubertal gynecomastia
HIV infection treated with antiretroviral therapy (ART), especially efavirenz or didanosine; breast enlargement resolves spontaneously in 73% within 9 months
++
++
Incidence appears to be increasing in all age groups
About 60% of boys develop pubertal gynecomastia, especially boys taller and heavier than average
Particularly common in teenagers who are very tall or overweight
About 20% of adult gynecomastia is caused by drug therapy
Fatty pseudogynecomastia is common among elderly men, particularly when there is associated weight gain
Develops in ~50% of athletes who abuse androgens and anabolic steroids
++
Female-appearing male breast
Graded according to severity: I (mild), II (moderate), III (severe)
Breast enlargement may be
Fatty
Usually diffuse
Nontender
Glandular
Asymmetric or unilateral, "lumpy"
Glandular enlargement beneath the areola, may be tender
Pubertal gynecomastia: tender discoid enlargement of breast tissue beneath the areola, 2–3 cm in diameter
The following characteristics are worrisome for malignancy
Asymmetry
Location not immediately below the areola
Unusual firmness
Nipple retraction, bleeding, or discharge
Testicular examination must be done, may reveal neoplasm
Examination must also include